Patient-Centred Outcomes Research and Policy Lead, Global Clinical Development @ UCB
5 free lookup(s). No credit card required.
Thomas Morel Location
Basel, BS, CH
Thomas Morel Work
2017 -
now Patient-Centred Outcomes Research and Policy Lead, Global Clinical Development @
2013 -
2017 Associate Director, Early Products Market Access and PRO Strategy @
2023 -
2025 Industry Chair, Critical Path Parkinson's Patient-Centric Endpoints Group @
2019 -
2025 Member of the Therapies Scientific Committee (TSC) @
2019 -
2022 Member - Innovative methodologies for clinical studies in rare diseases taskforce @ European Joint Programme on Rare Diseases
2011 -
2022 Research Fellow, Clinical Pharmacology and Pharmacotherapy @
2018 -
2019 Taskforce member - Orphan Drug Development Guidebook @
2016 -
2017 Team Lead - Taskforce on Patient-Centered Outcome Measures in Rare Diseases @
2007 -
2013 Manager, Health Economics and Outcomes Research group @
2003 -
2007 EU public affairs consultant @ Houston Consulting Europe
Thomas Morel Education
KU Leuven 2014
-
2019
King's College London 2004
-
2005
The London School of Economics and Political Science (LSE) 2001
-
2002
Thomas Morel Summary
Thomas Morel, based in Basel, BS, CH, is currently a Patient-Centred Outcomes Research and Policy Lead, Global Clinical Development at UCB. Thomas Morel brings experience from previous roles at UCB, Critical Path Institute (C-Path), International Rare Diseases Research Consortium (IRDiRC) and European Joint Programme on Rare Diseases. Thomas Morel holds a 2014 - 2019 KU Leuven. Thomas Morel has 3 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.